
    
      An open-label, prospective, and post-authorization observational study. This
      non-interventional study is designed to establish the importance of the measurement of HRQoL
      data and patient-reported outcomes in clinical practice in patients with RA, and to assess
      efficacy and safety use of CZP according to the summary of product characteristics.
    
  